Table 2 Clinical characteristics and triggering factors of adult patients with asthma attending ambulatory care units of selected public hospitals Northwestern Ethiopia, 2021 (N = 409)
Variable | Number (%) |
|---|---|
Age of onset (year) | |
 <  12 years | 98 (24%) |
 ≥ 12 years | 311 (76%) |
Duration on medication (years median (IQR)) | 3 (6) |
 < 1 year | 93 (22.7%) |
 1–5 years | 180 (44%) |
 5–10 years | 87 (21.3% |
 > 10 years | 49 (12%) |
Exacerbations in the last 12 months | |
 Yes | 217 (53.1%) |
 No | 192 (46.9%) |
Time to emergency visit after start of maintenance therapy (In month) (IQR) | 11.95 (13.6) |
Hospitalization in the last 12 months: | |
 Yes | 136 (33.3%) |
 No | 273 (66.7%) |
Admitted to ICU (intubated) in the last 12 months | |
 Yes | 25 (6.1%) |
 No | 284 (93.9%) |
Oral steroid use | |
 Yes | 152 (37.2%) |
 No | 257 (62.8%) |
Oral SABA use | |
 Yes | 253 (61.9%) |
 No | 156 (38.1%) |
Asthma severity stage | |
 Intermittent | 25 (6.1%) |
 Mild persistent | 107 (26.2%) |
 Moderate persistent | 232 (56.7%) |
 Severely persistent | 45 (11%) |
Lung function test (±SD) | |
 FEVs 1, percent predicted | 74.3 (5.31) |
 FVC 1, percent predicted | 78.08 (5.63) |
 FEV1,% predicted | 82.3 (9.45) |